Opinions
Jim Cramer - Mad Money
Vir Biotechnology
VIR-Q
DON'T BUY
Mar 15, 2023
N/A
Stock price when the opinion was issued
biotechnology
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
They generate cash, but also burn through it. He can't recommend any company not making money.